New York, NY, United States of America

Olcay Batuman

This inventor holds 1 USPTO granted patent. Top assignees: The State University of New York, University of Pittsburgh. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olcay Batuman. Retrieved from https://idiyas.com/inventor/olcay-batuman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olcay Batuman: Innovator in Cancer Treatment

Introduction

Olcay Batuman is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and patented methods. Her work focuses on utilizing heat shock proteins to develop effective therapies for Hsp70 dependent cancers.

Latest Patents

Olcay Batuman holds a patent for "Methods for heat shock protein dependent cancer treatment." This invention provides a method of treating Hsp70 dependent cancer by providing at least one Hsp70 dependent cancer cell. The method involves contacting the cancer cell with a sub-effective concentration of a dihydropyrimidinone compound and a proteasome inhibitor. The combination of these compounds has a synergistic effect on the cancer cell, enhancing treatment efficacy.

Career Highlights

Throughout her career, Olcay Batuman has worked with esteemed institutions such as the University of Pittsburgh and The State University of New York. Her research has contributed to advancements in cancer therapies, showcasing her dedication to improving patient outcomes.

Collaborations

Olcay has collaborated with notable professionals in her field, including Jeffrey L Brodsky. Their joint efforts have furthered research in cancer treatment methodologies.

Conclusion

Olcay Batuman's innovative work in cancer treatment exemplifies her commitment to advancing medical science. Her patented methods offer promising avenues for addressing Hsp70 dependent cancers, making her a valuable contributor to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…